RegWatch by RegulatorWatch.com
Jul 25, 2026 · 41 min · 14 segments
The deadliest nicotine products in America remain the easiest to buy, while lower-risk alternatives face the toughest fight for regulatory approval and political acceptance. It’s a striking contrast…
Laura Leigh OylerGuest
Brent StaffordHost
From a higher level, how much of the political and regulatory environment facing nicotine pouches today is a consequence of what happened with vaping?

Because I was working in government affairs back in 2015 and 2016, right around the time that really these products started to take off and get a lot of attention at the legislative level.

And I think that is the dynamic that I'm seeing play out over and over again, where You see the same state level efforts start to come into play, heavy levels of taxation on the products, flavor bans, retail restrictions, just a lot of barriers that start to pop up that look exactly like the barriers that we were seeing in the vape category.

I am also tracking vapor legislation, not just pouches, because I know that as laws start to move through committees and in and out of chambers, pouches may get added to a bill that's meant to address these cigarettes.

So they often get entangled from a regulatory perspective in a very practical way at the state level.

I mean, what's... difficult about it is that it's the same trusted public health voices that are saying it's the next jewel.

And so when I am in a state talking about these issues, I have to go back to the data because I find that quite often I'm up against emotion, I'm up against fear, but it really is that The pouch is being painted as though it's going to be this next gigantic public health problem.

From a higher level, how much of the political and regulatory environment facing nicotine pouches today is a consequence of what happened with vaping?

Because I was working in government affairs back in 2015 and 2016, right around the time that really these products started to take off and get a lot of attention at the legislative level.

And I think that is the dynamic that I'm seeing play out over and over again, where You see the same state level efforts start to come into play, heavy levels of taxation on the products, flavor bans, retail restrictions, just a lot of barriers that start to pop up that look exactly like the barriers that we were seeing in the vape category.

I am also tracking vapor legislation, not just pouches, because I know that as laws start to move through committees and in and out of chambers, pouches may get added to a bill that's meant to address these cigarettes.

So they often get entangled from a regulatory perspective in a very practical way at the state level.

I mean, what's... difficult about it is that it's the same trusted public health voices that are saying it's the next jewel.

And so when I am in a state talking about these issues, I have to go back to the data because I find that quite often I'm up against emotion, I'm up against fear, but it really is that The pouch is being painted as though it's going to be this next gigantic public health problem.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.